Skip to content
Politics & Current Affairs

Is the F.D.A. an Arm of the Pharmaceutical Industry?

Such a protracted legal process is required to make health claims about certain foods that the only the pharmaceutical industry is trusted as the arbiter of what is healthy. 
Sign up for the Smarter Faster newsletter
A weekly newsletter featuring the biggest ideas from the smartest people

What’s the Latest Development?


Under current legislation, it is illegal to make claims about the health benefits of food products without those products undergoing rigorous testing. While these requirements are ostensibly meant to protect and benefit the consumer, their true function is to guarantee the pharmaceutical industry a monopoly over health claims. “A drug is not defined by its molecular composition but as anything that claims that it can be used to mitigate disease.” Given this definition, known health benefits of certain foods compete with new medicines. 

What’s the Big Idea?

Were a food manufacturer to make claims about the health benefits of eating a particular food, unless the claims were tested according to F.D.A. protocol, they would be illegal. While individuals should be protected from the charms of the snake oil salesman, the financial barrier to entry in bringing a new drug to market is too high. According to the Pharmaceutical Research and Manufacturers of America, developing, testing and approving a new drug costs over $500 million, effectively eliminating small food producers from making health claims. 

Sign up for the Smarter Faster newsletter
A weekly newsletter featuring the biggest ideas from the smartest people

Related
Our idea offers a solution for how the for-profit health insurance provider business model can be innovated on to not only allow for active participation and collaboration by policyholders in the creation of value, generate additional revenue and help finance the cost of health plans, but also provide for the realization of an improved, and invariably more productive alignment of interests and strategies across the entire healthcare value network.
Our idea offers a solution for how the for-profit health insurance provider business model can be innovated on to not only allow for active participation and collaboration by policyholders in the creation of value, generate additional revenue and help finance the cost of health plans, but also provide for the realization of an improved, and invariably more productive alignment of interests and strategies across the entire healthcare value network.

Up Next
We live in a culture that valorizes over-busyness. In so many workplaces, the hero is the one who is putting in the long hours. Why isn’t the hero the person who can get amazing work done and leave at a reasonable time?